Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jandeleit

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
Free Radical Research|November 14, 2018
A novel synthetic small molecule DMFO targets Nrf2 in modulating proinflammatory/antioxidant mediators to ameliorate inflammationGeetha Mathew, Arpeeta Sharma, Raelene J Pickering, et al.
Clinical Science (London, England : 1979)|April 15, 2014
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosisChristine Koulis, Peter Kanellakis, Raelene J Pickering, et al.
Frontiers in Physiology|May 2, 2019
Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen SpeciesAnna M D Watson, Eleanor A M Gould, Sally A Penfold, et al.
Hypertension (Dallas, Tex. : 1979)|March 18, 2015
AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathyChristine Koulis, Bryna S M Chow, Maria McKelvey, et al.
Diabetologia|October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosisY Pham, Y Tu, T Wu, et al.
Diabetologia|February 5, 2017
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular diseaseStephen P Gray, Jay C Jha, Kit Kennedy, et al.
Cardiovascular Diabetology|January 29, 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational studyAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Circulation|April 11, 2007
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient micePaul Lewis, Nada Stefanovic, Josefa Pete, et al.
Scientific Reports|July 7, 2022
Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosisFlorence Ho, Anna M D Watson, Mahmoud H Elbatreek, et al.
Free Radical Biology & Medicine|July 23, 2016
NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosisElyse Di Marco, Stephen P Gray, Kit Kennedy, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
Free Radical Research|November 14, 2018
A novel synthetic small molecule DMFO targets Nrf2 in modulating proinflammatory/antioxidant mediators to ameliorate inflammationGeetha Mathew, Arpeeta Sharma, Raelene J Pickering, et al.
Clinical Science (London, England : 1979)|April 15, 2014
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosisChristine Koulis, Peter Kanellakis, Raelene J Pickering, et al.
Frontiers in Physiology|May 2, 2019
Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen SpeciesAnna M D Watson, Eleanor A M Gould, Sally A Penfold, et al.
Hypertension (Dallas, Tex. : 1979)|March 18, 2015
AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathyChristine Koulis, Bryna S M Chow, Maria McKelvey, et al.
Diabetologia|October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosisY Pham, Y Tu, T Wu, et al.
Diabetologia|February 5, 2017
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular diseaseStephen P Gray, Jay C Jha, Kit Kennedy, et al.
Cardiovascular Diabetology|January 29, 2026
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational studyAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Circulation|April 11, 2007
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient micePaul Lewis, Nada Stefanovic, Josefa Pete, et al.
Scientific Reports|July 7, 2022
Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosisFlorence Ho, Anna M D Watson, Mahmoud H Elbatreek, et al.
Free Radical Biology & Medicine|July 23, 2016
NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosisElyse Di Marco, Stephen P Gray, Kit Kennedy, et al.
Pageof 19